These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
    Author: Aktas O, Waiczies S, Zipp F.
    Journal: J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462.
    Abstract:
    Multiple sclerosis (MS) is the most common chronic demyelinating disease of the central nervous system (CNS) and the major cause of neurological disability in young adults in Western countries. In spite of intensive research efforts, treatment options established to date do not sufficiently prevent the accumulation of tissue damage and clinical disability in patients with MS. We here describe recently identified molecules responsible for the inflammatory and the neurodegenerative processes in MS and its animal model, experimental autoimmune encephalomyelitis (EAE), and review new treatment options targeting both aspects of this disease.
    [Abstract] [Full Text] [Related] [New Search]